"El Centro de Oftalmología Barraquer es una institución médica líder en la prevención, el diagnóstico y el tratamiento de enfermedades oculares. Desde 1941 ofrece asistencia oftalmológica integral a pacientes de todo el mundo gracias a un equipo médico formado por más de 30 oftalmólogos altamente especializados y de reconocido prestigio profesional. Además de brindar una calidad humana diferencial en su trato al paciente, el Centro diversifica su actividad con otras tres áreas de actuación: formación, investigación y labor social. Con una constante actualización, Barraquer conserva su esencia y sigue desarrollando el proyecto original, consolidando su posición de referencia internacional y de excelencia en su especialidad."

During the past decade, Centro de Oftalmologia Barraquer conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Oftalmologia Barraquer" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Allergan" with 2 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored, "Avizorex Pharma, S.L." with 1 trials sponsored and "Immunovant Sciences GmbH" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Oftalmologia Barraquer" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Oftalmologia Barraquer" are "Diabetic Macular Edema" (2 trials), "Central Retinal Vein Occlusion" (1 trials), "Diabetic Retinopathy" (1 trials), "Dry Eye Disease" (1 trials) and "Dry Eye Syndrome" (1 trials). Many other conditions were trialed in "Centro de Oftalmologia Barraquer" in a lesser frequency.

Most popular intervention types in "Centro de Oftalmologia Barraquer" are "Drug" (13 trials), "Other" (4 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (4 trials), "Faricimab" (3 trials), "Aflibercept" (2 trials), "Ranibizumab" (2 trials) and "AVX012 Ophthalmic Solution High dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Oftalmologia Barraquer" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Oftalmologia Barraquer". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centro de Oftalmologia Barraquer, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Oftalmologia Barraquer, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".